U.S. EPA Repeal Greenhouse Finding: Investor Uncertainty and Transition Costs

The Trump administration plans to formally rescind the 2009 scientific finding that linked carbon dioxide to health risks, the legal basis for over 15 years of greenhouse gas regulations. This rollback, intended to roll back fossil fuel development and slow clean energy, will create regulatory uncertainty and stranded asset risk for companies already investing in low-carbon transitions. Shareholder advocates warn the repeal will add operational costs and disrupt capital expenditure planning, with potential whiplash if future administrations reverse course. While U.S. multinationals may face less immediate impact from the repeal, global and EU regulations will remain in place. Legal challenges loom after a federal court found the Department of Energy violated the law in forming a climate science advisory group to support the repeal. Investor demand for climate risk accountability is unlikely to waver,摁ning pressure on companies to maintain their net-zero commitments and ESG integration.